Konstantinos Rounis

Irakleion, ESYE43 71110, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

MEK inhibition in adult patients with pilocytic astrocytomas.

MEK inhibition in adult patients with pilocytic astrocytomas.

Journal: NPJ precision oncology

Published: October 11, 2025

PD-1 expression in tumor infiltrating lymphocytes as a prognostic marker in early-stage non-small cell lung cancer.

PD-1 expression in tumor infiltrating lymphocytes as a prognostic marker in early-stage non-small cell lung cancer.

Journal: Frontiers in oncology

Published: April 09, 2024

Correction: Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.

Correction: Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.

Journal: PloS one

Published: November 09, 2023

Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study.

Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study.

Journal: PloS one

Published: November 09, 2023

Plasma-Based microRNA Expression Analysis in Advanced Stage NSCLC Patients Treated with Nivolumab.

Plasma-Based microRNA Expression Analysis in Advanced Stage NSCLC Patients Treated with Nivolumab.

Journal: Cancers

Published: July 12, 2022

Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.

Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.

Journal: PloS one

Published: May 19, 2022

Cancer Cachexia and Antitumor Immunity: Common Mediators and Potential Targets for New Therapies.

Cancer Cachexia and Antitumor Immunity: Common Mediators and Potential Targets for New Therapies.

Journal: Life (Basel, Switzerland)

Published: May 19, 2022

Complications following novel therapies for non-small cell lung cancer.

Complications following novel therapies for non-small cell lung cancer.

Journal: Journal of internal medicine

Published: January 15, 2022

A Prognostic Role for Circulating microRNAs Involved in Macrophage Polarization in Advanced Non-Small Cell Lung Cancer.

A Prognostic Role for Circulating microRNAs Involved in Macrophage Polarization in Advanced Non-Small Cell Lung Cancer.

Journal: Cells

Published: July 07, 2021

Circulating miRNAs as Potential Biomarkers in Prostate Cancer Patients Undergoing Radiotherapy.

Circulating miRNAs as Potential Biomarkers in Prostate Cancer Patients Undergoing Radiotherapy.

Journal: Cancer management and research

Published: June 17, 2021

Cancer cachexia syndrome and clinical outcome in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: results from a prospective, observational study.

Cancer cachexia syndrome and clinical outcome in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: results from a prospective, observational study.

Journal: Translational lung cancer research

Published: June 03, 2021

High Density of NRF2 Expression in Malignant Cells Is Associated with Increased Risk of CNS Metastasis in Early-Stage NSCLC.

High Density of NRF2 Expression in Malignant Cells Is Associated with Increased Risk of CNS Metastasis in Early-Stage NSCLC.

Journal: Cancers

Published: April 29, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026